IP Verse

Brand Murray Fuller competitive analysis

Explore patent oppositions filed by Brand Murray Fuller against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP3984538	Methods Of Treating Fabry Disease In Patients Having A Mutation In The Gla Gene	AMICUS THERAPEUTICS	Aug 5, 2026
EP2396005	Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or Hyperglycemia	BOEHRINGER INGELHEIM	Aug 3, 2026
EP4374919	Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 29, 2026
EP4476336	Reference Beads For Linking Imaging And Sequencing Readouts With Single-Cell Resolution	BECTON	Jul 29, 2026
EP3858859	Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)	BRISTOL MYERS SQUIBB	Jul 28, 2026
EP4188389	Methods Of Treating Chronic Kidney Disease With Dapagliflozin	ASTRAZENECA	Jun 16, 2026
EP4385509	Migalastat Formulations Having Improved Pharmacokinetics	AMICUS THERAPEUTICS	Jun 3, 2026
EP4374918	Methods Of Treating Fabry Patients Having Renal Impairment	AMICUS THERAPEUTICS	Apr 15, 2026
EP4403228	Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor Pertuzumab	F HOFFMANN LA ROCHE	Apr 8, 2026
EP4188327	Combination Therapy For Inhalation Administration	CHEMO RESEARCH	Feb 26, 2026

Discover the latest PTAB cases involving Brand Murray Fuller, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Brand Murray Fuller with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BRAND MURRAY FULLER SERVICES	2	-	-	-
BOEHRINGER INGELHEIM	45	232	8	9